Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV
Jessica J. Wyse, Kathleen A. McGinnis, E. Jennifer Edelman, Adam J. Gordon, Ajay Manhapra, David A. Fiellin, Brent A. Moore, P. Todd Korthuis, Amy J. Kennedy, Benjamin J. Oldfield, Julie R. Gaither, Kirsha S. Gordon, Melissa Skanderson, Declan T. Barry, Kendall Bryant, Stephen Crystal, Amy C. Justice, Kevin L. Kraemer
Topics & Concepts
BuprenorphineOpioid use disorderMedicineMethadoneOpiate Substitution TreatmentOpioidHealth psychologyRetention rateCohortPublic healthAgonistInternal medicinePsychiatryAnesthesiaComputer securityReceptorNursingComputer scienceOpioid Use Disorder TreatmentHIV, Drug Use, Sexual RiskPrenatal Substance Exposure Effects